Sequoia Financial Advisors LLC Boosts Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Sequoia Financial Advisors LLC boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 7.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,109 shares of the company’s stock after acquiring an additional 412 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Henry Schein were worth $423,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of HSIC. Versant Capital Management Inc grew its position in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC raised its position in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC lifted its stake in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank purchased a new position in shares of Henry Schein in the fourth quarter worth about $55,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.3 %

Shares of NASDAQ HSIC opened at $72.00 on Wednesday. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm’s 50-day moving average price is $74.85 and its 200-day moving average price is $72.63. The stock has a market capitalization of $8.94 billion, a price-to-earnings ratio of 29.63, a P/E/G ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.66 earnings per share. On average, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.